COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2019 Ni Wang, MD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
  • 2025 Sarah Brandt
  • 2025 Kasper Rasmussen
  • 2025 Mathias Melgaard
  • 2026 Michael Widdowson
  • 2026 Jie Jiang
  • 2026 Kristina Aagaard
  • 2026 Frederikke Skov
  • 2026 Trine Mølbæk-Engbjerg
  • 2026 Kasper Fischer-Rasmussen
  • 2026 Tamo Sultan
Home Home Dissemination Theses 2019 Ni Wang, MD

Deregulated Immune Response in Early Life and The Development of Asthma

By Ni Wang

Summary

Chariman: Janne Marie Moll

Opponent: Harald Renz

Opponent: Peter M. H. Heegaard

Opponent: Anders Elm Pedersen

ABSTRACT

The prevalence of non-communicable diseases (NCDs) such as diabetes, asthma and mental disorders have been rising worldwide during the last decades. Those NCDs are suggested to be based on a common reason, as they can all be explained as the “altered reactivity” of the human body to the mismatched total modern environment. Among all forms of NCDs, childhood atopic diseases including asthma, allergic rhinitis and food allergy have attracted a lot of attention and have been extensively studied as they manifest during early life and may serve as an indicator of the altered immune system and forerunner of other forms of NCDs.

This PhD study aimed to investigate potential early life immune mechanisms underlying the development of asthma and other forms of allergic disorders. We hypothesized that a deregulated immune response to specific microorganisms in early life may result in inefficient removal of these infectious agents and subsequently result in exaggerated immune activity, in continuous or recurrent infections, and in development of asthma or allergic sensitization.

The hypothesis was studied by using data based on ex vivo stimulated cytokine release from peripheral blood mononuclear samples collected at 6-month-of age from children followed consecutively from birth to school age for collection of environmental exposure and clinical data. Immune response data were based on stimulation of immune cells with whole airway bacteria or pathogen associated components activating different adaptive or innate immune responses.

From examining cytokine production in response to three selected airway bacteria, we identified a reduced IL-2 production to link with increased levels of total IgE at the age of 6 years. Moreover, we also found that reduced IL-2 in combination with elevated IL-5 associated with increased risk of allergic rhinitis at the age of 7 years. These results provided evidence to support an association between a deregulated immune response against certain bacteria in early life and later allergic sensitization.

We also identified an IL-23-biased innate immune response against viral and bacterial derived nucleic acids to underline the association between asthma risk SNPs and childhood asthma. This result suggested that the link between the 17q21 asthma risk and asthma development is partly mediated via a deficient innate immune response to intracellular pathogens in early life. This result did not only provide evidence to support the hypothesis about deregulated innate immune function, but also pointed to a mechanism for how the 17q21 locus variants may increase the risk of developing childhood asthma.

Altogether, we here provide evidence for two different deregulated immune mechanisms in infants which couple pathogenic colonization in the airways in early life to later asthma development or allergic sensitization at school age.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC